- Latest available (Revised)
- Point in Time (18/05/2004)
- Original (As made)
Version Superseded: 19/11/2004
Point in time view as at 18/05/2004.
There are currently no known outstanding effects for the The Prescription Only Medicines (Human Use) Order 1997, SCHEDULE 3A.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Article 3A
Textual Amendments
F1Sch. 3A inserted (1.4.2002) by The Prescription Only Medicines (Human Use) Amendment Order 2002 (S.I. 2002/549), arts. 1(1), 9
Column 1 | Column 2 |
---|---|
Substance | Requirements as to use, route of administration, or pharmaceutical form |
Aciclovir | External use |
Acrivastine | Oral |
Adapalene | External use |
Alclometasone dipropionate | External use |
Alimemazine tartrate (trimeprazine tartrate) | Oral |
[F2Amitriptyline hydrochloride | Oral] |
Amorolfine hydrochloride | External use |
Amoxycillin trihydrate | Oral |
Aspirin | Oral |
Azelaic acid | External use |
Azelastine hydrochloride | Ophthalmic use or nasal |
[F2Azithromycin dihydrate | Oral] |
Baclofen | Oral administration in palliative care |
Beclometasone dipropionate | External use or nasal |
Betamethasone dipropionate | External use |
Betamethasone sodium phosphate | Aural or nasal |
Betamethasone valerate | External use |
Budesonide | Nasal |
[F2Carbamazepine | Oral or rectal] |
Carbaryl | External use |
Carbenoxolone sodium | Mouthwash |
Cetirizine hydrochloride | Oral |
Chloramphenicol | Ophthalmic use |
Cimetidine | Oral |
Cinchocaine hydrochloride | External use |
[F2Clavulanic acid [F3(as potassium clavulanate)] | Oral] |
Clindamycin phosphate | External use |
Clobetasone butyrate | External use |
Clotrimazole | External use |
[F4Codeine Phosphate | Oral] |
[F2Conjugated oestrogens (equine) | External use] |
[F4Co-Phenotrope | Oral] |
Cyclizine | Parenteral administration in palliative care |
Dantrolene sodium | Oral administration in palliative care |
Dantron | Oral |
Desogestrel | Oral |
Desoximetasone (Desoxymethasone) | External use |
Dexamethasone | Aural |
Dexamethasone isonicotinate | Nasal |
[F4Diazepam | Oral, parenteral or rectal administration in palliative care] |
Diclofenac diethylammonium | External use |
[F2Diclofenac potassium | Oral] |
[F2Diclofenac sodium | Oral or rectal] |
[F4Dihydrocodeine Tartrate | Oral] |
Domperidone | Oral or rectal administration in palliative care |
Domperidone maleate | Oral administration in palliative care |
Doxycycline [F5hyclate] | Oral |
[F6Doxycycline monohydrate | Oral] |
Econazole nitrate | External use |
[F6Emedastine | Ophthalmic use] |
Erythromycin | External use [F7or oral] |
[F2Erythromycin ethyl succinate | Oral] |
[F2Erythromycin stearate | Oral] |
[F2Estradiol | External use] |
[F2Estriol | External use] |
Ethinylestradiol | Oral |
[F2Etonogestrel | Implant] |
Etynodiol diacetate (ethynodiol diacetate) | Oral |
Famotidine | Oral |
Felbinac | External use |
Fenticonazole nitrate | External use |
Fexofenadine hydrochloride | Oral |
[F6Flucloxacillin magnesium | Oral] |
Flucloxacillin sodium | Oral |
Fluconazole | Oral |
Fludroxycortide (Flurandrenolone) | External use |
[F2Flumazenil | Parenteral] |
Flumetasone pivalate | Aural |
Flunisolide | Nasal |
Fluocinolone acetonide | External use |
Fluocinonide | External use |
Fluocortolone hexanoate | External use |
Fluocortolone pivalate | External use |
Flurbiprofen | Lozenges |
Fluticasone propionate | External use or nasal |
Fusidic acid | [F8External Use] |
[F2Gabapentin | Oral] |
Gentamicin sulphate | Aural |
Gestodene | Oral |
[F2Glucagon hydrochloride | Parenteral] |
[F2Glucose | Parenteral] |
Hydrocortisone | External use |
Hydrocortisone acetate | External use [F9or aural] |
Hydrocortisone butyrate | External use |
Hydrocortisone sodium succinate | Lozenges |
[F10Hyoscine | Transdermal administration in palliative care] |
Hyoscine butylbromide | Parenteral F11... administration in palliative care |
Hyoscine hydrobromide | [F12Oral or parenteral administration in palliative care] |
Ibuprofen | External use or oral |
Ibuprofen lysine | Oral |
[F2Imipramine hydrochloride | Oral] |
Ipratropium bromide | Nasal |
Isotretinoin | External use |
Ketoconazole | External use |
Ketoprofen | External use |
Levocabastine hydrochloride | Ophthalmic use or nasal |
Levomepromazine (methotrimeprazine) maleate | Oral administration in palliative care |
Levomepromazine (methotrimeprazine) hydrochloride | Parenteral administration in palliative care |
Levonorgestrel | Oral |
[F2Lignocaine hydrochloride | External use or parenteral] |
Lithium succinate | External use |
Lodoxamide trometamol | Ophthalmic use |
Loperamide hydrochloride | Oral |
Loratadine | Oral |
[F4Lorazepam | Oral or parenteral administration in palliative care] |
[F2Lymecycline | Oral] |
Mebendazole | Oral |
Medroxyprogesterone acetate | Parenteral |
Mestranol | Oral |
Metoclopramide hydrochloride | Oral or parenteral administration in palliative care |
Metronidazole | [F13External use, oral or rectal] |
Metronidazole benzoate | Oral |
Miconazole | Dental lacquer |
Miconazole nitrate | External use |
[F4Midazolam | Parenteral administration in palliative care] |
Minocycline | Oral |
[F6Mizolastine | Oral] |
[F6Minocycline hydrochloride | Oral] |
Mometasone furoate | External use or nasal |
Nedocromil sodium | Ophthalmic use |
Nefopam hydrochloride | Oral |
Neomycin sulphate | Aural |
Neomycin undecenoate | Aural |
Nitrofurantoin | Oral |
Nizatidine | Oral |
Norethisterone 9 | Oral |
Norethisterone acetate | Oral |
Norethisterone enanthate | Parenteral |
Norgestimate | Oral |
Norgestrel | Oral |
[F2Nortriptyline hydrochloride | Oral] |
Nystatin | External use |
Oxytetracycline dihydrate | Oral |
Paracetamol | Oral |
Penciclovir | External use |
Piroxicam | External use |
[F2Prednisolone | Oral] |
Prednisolone hexanoate | External use |
Prednisolone sodium phosphate | Aural [F14or oral] |
Ranitidine hydrochloride | Oral |
[F2Salbutamol sulphate | Inhalation] |
Silver sulphadiazine | External use |
Sodium cromoglycate | Ophthalmic use |
[F2Sodium fusidate | External use] |
Streptodornase | External use |
Streptokinase | External use |
Sulconazole nitrate | External use |
Terbinafine hydrochloride | External use |
[F2Terbutaline sulphate | Inhalation] |
Tetracycline hydrochloride | External use or oral |
Tretinoin | External use |
Triamcinolone acetonide | External use, aural, nasal or oral paste |
Trimethoprim | Oral |
Tuberculin PPD | Parenteral |
Vaccine, Adsorbed Diphtheria | Parenteral |
Vaccine, Adsorbed Diphtheria And Tetanus | Parenteral |
Vaccine, Adsorbed Diphtheria And Tetanus For Adults And Adolescents | Parenteral |
Vaccine, Adsorbed Diphtheria For Adults And Adolescents | Parenteral |
Vaccine, Adsorbed Diphtheria, Tetanus And Pertussis | Parenteral |
Vaccine, Adsorbed Diphtheria, Tetanus And Pertussis (Acellular Component) | Parenteral |
Vaccine, BCG | Parenteral |
Vaccine, BCG Percutaneous | Parenteral |
Vaccine, Haemophilus Influenzae Type B (Hib) | Parenteral |
Vaccine, Haemophilus Influenzae Type B (Hib) with Diphtheria, Tetanus And Pertussis | Parenteral |
Vaccine, Haemophilus Influenzae Type B, Diphtheria, Tetanus And Acellular Pertussis | Parenteral |
Vaccine, Hepatitis A | Parenteral |
Vaccine, Hepatitis A With Typhoid | Parenteral |
Vaccine, Hepatitis A, Inactivated, With Recombinant (DNA) Hepatitis B | Parenteral |
Vaccine, Hepatitis B | Parenteral |
Vaccine, Influenza | Parenteral |
Vaccine, Live Measles, Mumps And Rubella (MMR) | Parenteral |
Vaccine, Meningococcal Group C Conjugate | Parenteral |
Vaccine, Meningococcal Polysaccharide A and C | Parenteral |
Vaccine, Pneumococcal | Parenteral |
F15. . . | F15. . . |
Vaccine, Poliomyelitis, Live (Oral) | Oral |
Vaccine, Rubella, Live | Parenteral |
Vaccine, Tetanus, Adsorbed | Parenteral |
Vaccine, Typhoid, Live Attenuated (Oral) | Oral |
Vaccine, Typhoid, Polysaccharide | Parenteral |
[F6Water for Injections | Parenteral]] |
Textual Amendments
F2Sch. 3A entries inserted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(g)
F3Words in Sch. 3A added (18.5.2004) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2004 (S.I. 2004/1189), arts. 1(1), 3(a)
F4Words in Sch. 3A inserted (10.12.2003) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2003 (S.I. 2003/2915), arts. 1(1), 3
F5Words in Sch. 3A inserted (4.4.2003) by The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 15(a)
F6Words in Sch. 3A inserted (4.4.2003) by The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 15(c)
F7Words in Sch. 3A inserted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(a)
F8Words in Sch. 3A substituted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(b)
F9Words in Sch. 3A added (18.5.2004) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2004 (S.I. 2004/1189), arts. 1(1), 3(b)
F10Words in Sch. 3A inserted (18.5.2004) by The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2004 (S.I. 2004/1189), arts. 1(1), 3(d)
F11Words in Sch. 3A omitted (18.5.2004) by virtue of The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2004 (S.I. 2004/1189), arts. 1(1), 3(c)
F12Words in Sch. 3A substituted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(d)
F13Words in Sch. 3A substituted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(e)
F14Words in Sch. 3A substituted (31.1.2004) by The Prescription Only Medicines (Human Use) Amendment Order 2004 (S.I. 2004/2), arts. 1(1), 3(f)
F15Words in Sch. 3A omitted (4.4.2003) by virtue of The Prescription Only Medicines (Human Use) Amendment Order 2003 (S.I. 2003/696), arts. 1(1), 15(b)
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: